Prostate-specific antigen (PSA) blood testing likely reduces the risk of death from prostate cancer, found a new review
Human prostate cancer cells, stained blue, shown under a microscope.Adobe
By Annalisa Merelli
May 14, 2026
Annalisa Merelli
Annalisa.Merelli@statnews.com
Prostate cancer screening can save lives but ‘absolute benefit is small’, study says
Prostate cancer screening through a blood test 'could reduce deaths'
Detección del cáncer de próstata: un estudio indica que la prueba de PSA podría ayudar a reducir muertes
Does the PSA test for prostate cancer save lives? New data reverse gold-standard findings
Cambian el consenso médico sobre la prueba de PSA para el cáncer de próstata como método para evitar muertes
Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment
A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths from…
Una revisión internacional muestra que los análisis de sangre para el antígeno prostático específico pueden prevenir…
New study found screening can reduce deaths by 13% but that overdiagnosis and subsequent overtreatment remain concerns
Health-evidence reviewers reverse recommendation on a blood test that detects a biomarker of a common cancer after decades of…
Decision over routine PSA testing is due at end of this month, though some feel the supporting data is unclear
